Background: The type IV collagen is a complex of trimetric molecule composed of six genetically distinct polypeptide chains; α1–6(IV). Since α3(IV) distribute specifically in the glomerular basement membrane (GBM) of glomerular capillary, we tried to develop the detection methods for the transcripts of α3(IV) in glomerular epithelial cells (GEC) which produce most of the components for GBM. Then, using these molecular techniques, the influence of elastase, one of the proteases released from activated polymorphonuclear leukocytes at the site of inflammation, on GEC was determined as manifested by expressional alteration of α3(IV) mRNA. Methods: DIG-labeled oligo-DNA probe designating non-collagenous region of α3(IV) was used for in situ hybridization. Semiquantitative measurement of α3(IV) in the renal cortex was performed by PCR reactions, each reaction being normalized by that for GAPDH. Then, the femoral artery of each of 18 Sprague-Dawley rats was catheterized and the left kidney was perfused with saline alone (0.5 ml) or saline containing 100 µg/ml elastase. After collection of urine for 24 h, the left kidney was harvested for analysis of mRNA (4 for in situ hybridization and 5 kidneys for PCR analysis). Results: Antisense cDNA probe and PCR reaction well identified α3(IV) mRNA in the cytoplasm of GEC and in the renal cortex, respectively. Urinary protein excreted by rats with elastase perfusion was 47.2 ± 3.8 mg/24 h but this was only 13.9 ± 1.1 mg/24 h in control rats (mean ± SEM, p < 0.05). In situ hybridization demonstrated that expression of α3(IV) mRNA in GEC was focally or diffusely reduced in the glomeruli of rats with elastase perfusion, whereas the transcripts were well stained in GEC of controls. PCR analysis showed about 25% decrease in transcripts of α3(IV) in the renal cortex of rats with elastase perfusion compared to those of control rats. Conclusions: α3(IV) mRNA was identified specifically in the GEC in the glomeruli. Co-incidence of proteinuria and reduced α3(IV) expression by elastase suggests adverse effects of elastase on GEC and close association between proteinuria and GEC injury.

Keywords:
Glomerular basement membrane, Proteinuria, Polymorphonuclear leukocytes
1.
Mundel P, Kriz W: Structure and function of podocytes: An update. Anat Embryol 1995;192:385–397.
2.
Watanabe H, Sakai T, Kobayashi N, Fukuda Y, Yabuta K: Glomerular basement membrane ourpockets and glomerular growth in the postnatal development of the kidney. Pediatr Nephrol 1996;10:461–466.
3.
Nagata M, Watanabe T: Podocytes in metanephric organ culture express characteristic in vivo phenotype. Histochem Cell Biol 1997;108:17–25.
4.
Timpl R, Wiedemann H, Van Delden V, Furthmayr H, Kuhn K: A network model for the organization of type IV collagen molecules in basement membrane. Eur J Biochem 1981;120:203–211.
5.
Hudson BG, Reeders ST, Tryggvason K: Type IV collagen: Structure, gene organization, and role in human disease. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis. J Biol Chem 1993;268:26033–26036.
6.
Zhou J, Ding M, Zhao ZH, Reeders ST: Complete primary structure of the sixth chain of human, basement membrane collage, alpha 6(IV): Isolation of the cDNAs for alpha 6(IV) and comparison with five other type IV collagen chains. J Biol Chem 1994;269:13193–13199.
7.
Sado Y, Kagawa M, Kishiro Y, Sugihara K, Naito I, Seyer JM, Sugimoto M, Oohashi T, Nijnomiya Y: Establishment by the rat lymph node method of epitope-defined monoclonal antibodies recognizing the six different α chains of human type IV collagen. Histochem Cell Biol 1995;104:267–275.
8.
Nonomiya Y, Kagawa M, Iyama K, Naito I, Kishiro Y, Seyer JM, Sugimoto M, Oohashi T, Sado Y: Differential expression of two basement membrane collagen genes, COL4A6 and COL4A5, demonstrated by immunofluorescence staining using peptide-specific monoclonal antibodies. J Cell Biol 1995;130:1219–1229.
9.
Baricos WH, Shah SV: Proteolytic enzymes as mediators of glomerular injury. Kidney Int 1991;40:161–173.
10.
Shah SV, Baricos WH, Basci A: Degradation of human glomerular basement membrane by stimulated neutrophils. J Clin Invest 1987;79:25–31.
11.
Johnson RJ, Couser WG, Alpers CE, Vissers M, Schulze M, Klebanoff SJ: The human neutrophil serine proteinase, elastase and cathepsin G, can mediate glomerular injury in vivo. J Exp Med 1988;169:1169–1174.
12.
Johnson RJ, Lovett D, Lehrer RI, Couser WG, Klebanoff SJ: Role of oxidants and proteases in glomerular injury. Kidney Int 1994;45:352–359.
13.
Heeringa P, Van Den Born J, Brouwer E, Dolmam KM, Huitema MG, Limburg PC, Bakker MAH, Berden JHM, Daha MR, Kallenber CGM: Elastase, but not proteinase 3 (PR3), induced proteinuria associated with loss of glomerular basement membrane heparan sulphate after in vivo renal perfusion in rats. Clin Exp Immunol 1996;105:321–329.
14.
Klebanoff SJ, Kinsella MG, Wight TN: Degradation of endothelial cell matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H2O2-chloride system. Am J Pathol 1993;143:907–917.
15.
Ballieux BEPB, Hiemstra PS, Klar-Mohamad N, Hagen EC, van Es LA, van der Woude FJ, Daha MR: Detachment and cytolysis of endothelial cells by proteinase 3. Eur J Immunol 1994;24:3211–3215.
16.
Michimata M, Nogae S, Ohta M, Kaizuma S, Imai Y, Ito S, Matsubara M: Topographic distribution of aquaporin 2 mRNA in the kidney of dehydrated rats. Exp Nephrol 2000;8:28–36.
17.
Nogae S, Michimata M, Kanazawa M, Honda S, Ohta M, Imai Y, Ito S, Matsubara M: Cardiac infarcts increase sodium transporter transcripts (rBSC1) in the thick ascending lim of Henle. Kidney Int 2000;57:2055–2063.
18.
Marumo M, Kaizuma S, Nogae S, Kanazawa M, Kimura T, Saito T, Ito S, Matsubara M: Differential upregulation of rat Na-K Cl cotransporter, rBSC1, mRNA in the thick ascending limb. Kidney Int 1998;54:877–888.
19.
Michimata M, Wang W, Fujita S, Haruo M, Fujimori K, Satomi S, Ohta M, Ito S, Kimura T, Araki T, Imai Y, Matsubara M: Limited urinary concentration and damaged tubules in rats with a syngeneic kidney graft. Kidney Int 2002;60:672–679.
20.
Matsubara M, Taguma Y, Kurosawa K, Hotta O, Suzuki K, Futaki G: Effect of camostat mesilate on heavy proteinuria in various nephropathies. Clin Nephrol 1989;32:119–123.
21.
Matsubara M, Taguma Y, Saito T, Yoshinaga K: Effect of camostat mesilate on persistent proteinuria of IgA nephropathy. Nephron 1992;60:244–245.
22.
Matsubara M, Taguma Y, Kurosawa K, Hotta O, Suzuki K, Ishizaki M: Effect of camostat mesilate for the treatment of advanced diabetic nephropathy. J Lab Clin Med 1990;116:20–210.
23.
Kinukawa Y, Shimura M, Tamai M: Quantifying leukocyte dynamics and plugging in retinal microcirculation of streptozotosin-induced diabetic rats. Curr Eye Res 1999;18:49–55.
© 2002 S. Karger AG, Basel
2002
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.